person · Reporting owner
McCarthy Cornelius P. III
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | Director | September 30, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,303 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Exercise / conversion · Acquired 28 · Balance 12,303 F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 28 |
Reported balance
After 2026-09-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-30 · Exercise / conversion · Disposed 28 · Balance 28 F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2: On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
F2: On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 21:19 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 28 | $0.00 | $0.00 |
DisclosureSEC source: 0001750355-26-000014 · wk-form4_1790975943.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28 Underlying: Common Stock · 28 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. F2 · derivative.expiration_date: On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 21:19 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 28 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001750355-26-000014 · wk-form4_1790975943.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,140 | $605.37 | $690,121.80 |
DisclosureSEC source: 0001750355-26-000012 · wk-form4_1786651935.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,275 Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:09 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,858 | $0.00 Strike: $84.36 | $0.00 |
DisclosureSEC source: 0001750355-26-000010 · wk-form4_1786478970.xml · derivative · entry 3 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,858 shares Expires 2027-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on May 13, 2021. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:09 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 795 | $585.07 | $465,131.45 |
DisclosureSEC source: 0001750355-26-000010 · wk-form4_1786478970.xml · nonDerivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,415 Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:09 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,858 | $84.36 | $325,460.88 |
DisclosureSEC source: 0001750355-26-000010 · wk-form4_1786478970.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 28 | $0.00 | $0.00 |
DisclosureSEC source: 0001750355-26-000008 · wk-form4_1783023147.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56 Underlying: Common Stock · 28 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. F2 · derivative.expiration_date: On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 28 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001750355-26-000008 · wk-form4_1783023147.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| May 15, 2026 Filed May 18, 2026 21:23 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,110 | $0.00 Strike: $415.27 | $0.00 |
DisclosureSEC source: 0001750355-26-000006 · wk-form4_1779139415.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,110 Underlying: Common Stock · 1,110 shares Expires 2033-05-15 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:49 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 29 | $0.00 | $0.00 |
DisclosureSEC source: 0001750355-26-000004 · wk-form4_1775162980.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84 Underlying: Common Stock · 29 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. F2 · derivative.expiration_date: On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:49 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 29 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001750355-26-000004 · wk-form4_1775162980.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001750355-26-000002 · wk-form4_1767648276.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 29, 2024, the Reporting Person was granted 198 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2025. F2 · derivative.expiration_date: On November 29, 2024, the Reporting Person was granted 198 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 49 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001750355-26-000002 · wk-form4_1767648276.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 21:38 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 113 | $592.46 | $66,947.98 |
DisclosureSEC source: 0001750355-25-000007 · wk-form4_1764711528.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113 Underlying: Common Stock · 113 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001750355-25-000005 · wk-form4_1759436195.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49 Underlying: Common Stock · 49 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 29, 2024, the Reporting Person was granted 198 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: On November 29, 2024, the Reporting Person was granted 198 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 49 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001750355-25-000005 · wk-form4_1759436195.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:56 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,662 | $465.04 | $772,896.48 |
DisclosureSEC source: 0001668397-25-000104 · wk-form4_1755809763.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,197 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $465.022 to $465.355. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 20:31 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,972 | $0.00 Strike: $54.99 | $0.00 |
DisclosureSEC source: 0001668397-25-000091 · wk-form4_1753389059.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,972 shares Expires 2026-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on May 14, 2020. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 20:31 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 1,972 | $54.99 | $108,440.28 |
DisclosureSEC source: 0001668397-25-000091 · wk-form4_1753389059.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 20:36 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $54.99 | $0.00 |
DisclosureSEC source: 0001668397-25-000089 · wk-form4_1753216585.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,972 Underlying: Common Stock · 4,500 shares Expires 2026-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on May 14, 2020. Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 20:36 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 4,500 | $54.99 | $247,455.00 |
DisclosureSEC source: 0001668397-25-000089 · wk-form4_1753216585.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:23 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-25-000079 · wk-form4_1751487814.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98 Underlying: Common Stock · 50 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 29, 2024, the Reporting Person was granted 198 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: On November 29, 2024, the Reporting Person was granted 198 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:23 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 50 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-25-000079 · wk-form4_1751487814.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:51 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,224 | $0.00 Strike: $305.66 | $0.00 |
DisclosureSEC source: 0001668397-25-000071 · wk-form4_1747774279.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,224 Underlying: Common Stock · 1,224 shares Expires 2032-05-16 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:40 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-25-000050 · wk-form4_1743630040.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148 Underlying: Common Stock · 50 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 29, 2024, the Reporting Person was granted 198 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: On November 29, 2024, the Reporting Person was granted 198 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:40 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 50 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-25-000050 · wk-form4_1743630040.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,337 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 62 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-25-000006 · wk-form4_1735940744.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 62 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-25-000006 · wk-form4_1735940744.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:36 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 198 | $340.63 | $67,444.74 |
DisclosureSEC source: 0001668397-24-000176 · wk-form4_1733261772.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198 Underlying: Common Stock · 198 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:41 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 62 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000161 · wk-form4_1727901687.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62 Underlying: Common Stock · 62 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:41 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 62 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000161 · wk-form4_1727901687.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 62 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000129 · wk-form4_1719951463.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124 Underlying: Common Stock · 62 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 62 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000129 · wk-form4_1719951463.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:49 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 953 | $0.00 Strike: $393.30 | $0.00 |
DisclosureSEC source: 0001668397-24-000115 · wk-form4_1716324582.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 953 Underlying: Common Stock · 953 shares Expires 2031-05-17 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 21:55 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 63 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000074 · wk-form4_1712094937.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186 Underlying: Common Stock · 63 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 21:55 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 63 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000074 · wk-form4_1712094937.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,710 | $0.00 Strike: $57.17 | $0.00 |
DisclosureSEC source: 0001668397-24-000007 · wk-form4_1707771991.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,710 shares Expires 2025-08-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on May 16, 2019. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 4,710 | $57.17 | $269,270.70 |
DisclosureSEC source: 0001668397-24-000007 · wk-form4_1707771991.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 21:21 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0000892251-24-000011 · form4.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023. F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 21:21 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 82 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000892251-24-000011 · form4.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:43 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 249 | $270.72 | $67,409.28 |
DisclosureSEC source: 0000892251-23-000198 · form4.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249 Underlying: Common Stock · 249 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024. F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0000892251-23-000146 · form4.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82 Underlying: Common Stock · 82 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 82 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000892251-23-000146 · form4.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0000892251-23-000074 · form4.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164 Underlying: Common Stock · 82 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 82 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000892251-23-000074 · form4.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,769 | $0.00 Strike: $210.88 | $0.00 |
DisclosureSEC source: 0000892251-23-000053 · form4.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,769 Underlying: Common Stock · 1,769 shares Expires 2030-05-19 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0000892251-23-000027 · form4.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246 Underlying: Common Stock · 82 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 82 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000892251-23-000027 · form4.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 328 | $205.77 | $67,492.56 |
DisclosureSEC source: 0001567619-22-021539 · doc1.xml · derivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328 Underlying: Common Stock · 328 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. F2 · derivative.expiration_date: The restricted stock units vest in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. Read SEC document |
| May 20, 2022 Filed May 24, 2022 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,903 | $0.00 Strike: $133.87 | $0.00 |
DisclosureSEC source: 0001567619-22-011618 · doc1.xml · derivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,903 Underlying: Common Stock · 1,903 shares Expires 2029-05-20 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.